Cargando…
Identification of PSMD14 as a potential novel prognosis biomarker and therapeutic target for osteosarcoma
BACKGROUND: Osteosarcoma is the most common primary bone tumor. The survival rate of osteosarcoma patients has not significantly increased in the past decades. Uncovering the mechanisms of malignancy, progression, and metastasis will shed light on the development of new therapeutic targets and treat...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9327663/ https://www.ncbi.nlm.nih.gov/pubmed/34383385 http://dx.doi.org/10.1002/cnr2.1522 |